[The treatment of helicobacteriosis in preventing postoperative inflammatory intraperitoneal complications in stomach cancer patients].
Patients with carcinoma of the stomach were studied for dependence of development of post-surgical complications on the Helicobacter pylori involvement of the gastric mucosa. As many as 100 percent of patients with carcinoma of the stomach were found out to have H. pylori. Patients with posttreatment inflammatory complications presented with high and moderate levels of H. pylori. A complex was inaugurated of preventive treatment for H. pylori involvement, with tetraciclini, vicalini, and metronidasoli. Incidence rate of postoperative complications was 5.7%, with no fatalities being recordable. In the oncological patient, treatment of the H. pylori involvement in the preoperative period makes for lowering of the initial level of endotoxicosis, which fact is conducive to decrease in the frequency of postoperative inflammatory complications.